Skip to content

Author

Rui-Feng Lin

We have 2 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

A pharmacist-led framework for antibiotic-associated liver injury: from pharmacovigilance signals to bedside surveillance with the updated RUCAM and susceptibility markers

Evidence on culprit antibiotics and their characteristic phenotypes, the mechanistic basis of susceptibility markers including HLA-B*57:01 and slow NAT2 acetylator status, the methods and limits of disproportionality analysis, and the pharmacist's role in medication review and monitoring are brought together.

Chao Liu, Dan Luo, Rui-Feng Lin · 0 citations
Open access Sep 2026

Machine learning models for predicting liver cancer: a real-world cohort study in China

The findings support the feasibility of leveraging large-scale inpatient laboratory data for risk-stratification model development and show good discrimination and interpretability for liver cancer prediction in a hospitalized real-world cohort using routinely available clinical and laboratory data.

Ce-Xiong Fu, Fang Li, Shi-Bing Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.